What is another name for newer, second-generation antipsychotic medications?

The term "atypical antipsychotics" refers to the class of newer antipsychotic medications that were developed after the first-generation antipsychotics. These medications are known for their distinct pharmacological profiles and mechanisms of action, which differentiate them from traditional antipsychotics. Atypical antipsychotics typically have a broader range of efficacy in treating symptoms of schizophrenia and other psychiatric disorders, including both positive symptoms (such as hallucinations and delusions) and negative symptoms (such as lack of motivation and social withdrawal).

This class of medications is characterized by a lower risk of extrapyramidal side effects, which are more common with first-generation antipsychotics. The improved side effect profile and the ability to treat a wider array of symptoms made atypical antipsychotics a significant advancement in psychiatric treatment.

Understanding this terminology is crucial for professionals in the mental health field, as it impacts treatment planning and patient management strategies.